SPRY4 and adenocarcinoma: Utilizing CRC patients in TCGA data repository, we found no group differences in SPRY4 transcript expression between patient adenocarcinomas identified as SPRY4-diploid or patients with copy number gains of SPRY4 (Figure 1e).